menu
    • menu

    Company profile for Ascendis Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained releas...
    Ascendis Pharma is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained-release technologies, to develop a pipeline of best‐in‐class therapeutics that address significant unmet medical needs. The TransCon technology can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ascendis PharmaDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    Tuborg Boulevard 12 2900 Hellerup Denmark
    Telephone
    Telephone
    +45 70 22 22 44
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ascendispharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ascendis-pharma-a-s/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Delays Decision On Ascendis' Dwarfism Prospect By 3 Months
    FDA Delays Decision On Ascendis' Dwarfism Prospect By 3 Months

    26 Nov 2025

    // PRESS RELEASE

    https://investors.ascendispharma.com/news-releases/news-release-details/ascendis-announces-extension-fda-review-period-transcon-cnp

    PRESS RELEASE
    26 Nov 2025
    Share Share
    FDA Extends Review of TransCon CNP for Pediatric Achondroplasia
    FDA Extends Review of TransCon CNP for Pediatric Achondroplasia

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194804/0/en/Ascendis-Announces-Extension-of-FDA-Review-Period-for-TransCon-CNP-navepegritide-for-Children-with-Achondroplasia.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Transcon CNP Trial In Children With Achondroplasia Published
    Transcon CNP Trial In Children With Achondroplasia Published

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189570/0/en/Results-of-Pivotal-ApproaCH-Trial-of-TransCon-CNP-Navepegritide-in-Children-with-Achondroplasia-Published-in-JAMA-Pediatrics.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    Ascendis Pharma Reports Third Quarter 2025 Financial Results
    Ascendis Pharma Reports Third Quarter 2025 Financial Results

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186726/0/en/Ascendis-Pharma-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Pooled 3-Year Data Confirms Renal Function Improvement
    Pooled 3-Year Data Confirms Renal Function Improvement

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183644/0/en/New-Pooled-3-Year-Analysis-Confirms-Sustained-Clinically-Meaningful-Improvements-in-Renal-Function-for-TransCon-PTH-Palopegteriparatide-Treated-Adults-with-Hypoparathyroidism.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Ascendis Pharma To Release Q3 2025 Financials & Business Results
    Ascendis Pharma To Release Q3 2025 Financials & Business Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181903/0/en/Ascendis-Pharma-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-Business-Update-on-November-12-2025.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search